Eli lilly will cut list price of most commonly prescribed forms of insulin Humalog and Humulin in the fourth quarter this year “Insulin Price Reduction by World Giant Pharm Companies in the USA (%) BY NOVO NORDISK BY SANOFI PHARMA BY ELI LILLY PHARMA 75% price cut for insulin products 78% price cut for insulin…
78% Price cut by Sanof Pharma: A Milestone for Diabetes Patients Major Price Reduction to Address Diabetes Care Sanofi Pharma, one of the largest global pharmaceutical companies, has announced a groundbreaking 78% reduction in insulin prices. This move aims to address the financial strain on diabetes patients, making lifesaving medication more accessible to millions worldwide….
75% Insulin price Cut by Novo Nordisk for insulin products in response to Public Pressure The announcement for substantial insulin price cut by Novo Nordisk n the list prices of several of its insulin products, with cuts of up to 75% set to take effect from January 2024. This move comes as part of the…
THE EXENATIDE A GLP-1 RECEPTORS AGONIST TREATES IIH, A BLINDING HEADACHE IN YOUNG OBESE WOMAN The new research was designed to investigate the potential therapeutic effect of GLP-1 receptor agonists on patients with idiopathic intracranial hypertension (IIH), a condition characterized by increased intracranial pressure (ICP) with no identifiable cause. GLP-1 receptor agonists are already used…
Are There Alternatives to Ozempic in the USA to face drug shortage. Ozempic, an injectable medication primarily used to manage type 2 diabetes, has seen a significant surge in demand in the USA, raising concerns about the supply chain. Manufactured by the pharmaceutical giant Novo Nordisk, Ozempic was approved by the FDA in 2017. The…
